Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Peace Sandy on 2024-3-27

Curated date: 2024/03/27

Curator: Peace Sandy

Revision editor(s): Peace Sandy

Source: Figure 4

Description: LEfSe analysis was used to statistically resolve the microbiota with significant effects in the different groups. The LDA threshold was set as 2. (A) The stage 4-5 CKD group and (B) the control group.

Abundance in Group 1: decreased abundance in Chronic kidney disease

NCBI	Quality Control	Links
Clostridia
Eubacteriales
Prevotella
Prevotellaceae
Faecalibacterium
Roseburia
Selenomonadales
Negativicutes
Lachnospiraceae
Acidaminococcaceae
Phascolarctobacterium
Lachnospiraceae incertae sedis
Veillonellaceae
Ruminococcus
Coprococcus
Dialister
Rikenellaceae
Alistipes
Oscillibacter
Sutterellaceae
Parasutterella
Rhodospirillaceae
Rhodospirillales
Asaccharobacter
Haemophilus
Oxalobacteraceae
Butyricicoccus
Oxalobacter
Slackia
Dorea
Fusicatenibacter
Holdemanella
Clostridium
Barnesiella
Romboutsia
Anaerostipes
Butyricimonas
Odoribacter
Acidaminococcus
Allisonella

Revision editor(s): Peace Sandy